Investec, the stock research arm of Barclays Bank, is making a strong recommendation to buy Barclays PLC (ADR) (NYSE:BCS) (LON:BARC) as it notes “discriminatory regulatory behavior” as a potential risk to the stock price. Investec notes Barclays underlines performance beat In a report titled “And now you’re gonna believe us…the tNAV’s going up!” the research arm of the bank noted a 25 percent underlying performance “beat” relative to consensus earnings estimates. Although the bank is facing adverse currency translations and announced Spanish issues, the report says “fear not,” as it sees “attributable profit of £0.1bn, but with a positive currency reserve move…
Barclays Bank 'Research Arm' Recommends Buying Barclays Stock
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.